Cover Image

An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury

Tong Yang,1 Xiangyu Chen,1 Zhigang Mei,1,2 Xiaolu Liu,2 Zhitao Feng,2 Jun Liao,1 Yihui Deng,1 Jinwen Ge1 1Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese and We...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yang T (Author), Chen X (Author), Mei Z (Author), Liu X (Author), Feng Z (Author), Liao J (Author), Deng Y (Author), Ge J (Author)
Format:	Book
Published:	Dove Medical Press, 2021-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota–Gut–Brain Axis
by: Nie H, et al.
Published: (2023)

Network Pharmacology Reveals the Mechanism of Activity of Tongqiao Huoxue Decoction Extract Against Middle Cerebral Artery Occlusion-Induced Cerebral Ischemia-Reperfusion Injury
by: Si-peng Wu, et al.
Published: (2021)

Quercetin Protects Against Global Cerebral ischemia‒reperfusion Injury by Inhibiting Microglial Activation and Polarization
by: Wang N, et al.
Published: (2024)

Ursolic acid reduces the metalloprotease/anti-metalloprotease imbalance in cerebral ischemia and reperfusion injury
by: Wang Y, et al.
Published: (2016)

Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration
by: Zhang H, et al.
Published: (2021)

Ursolic Acid Reduces the Metalloprotease/Anti-Metalloprotease Imbalance in Cerebral Ischemia and Reperfusion Injury [Corrigendum]
by: Wang Y, et al.
Published: (2021)

Network Pharmacology-Based Investigation and Experimental Exploration of the Antiapoptotic Mechanism of Colchicine on Myocardial Ischemia Reperfusion Injury
by: Yuanjun Tang, et al.
Published: (2021)

Network Pharmacology with Metabolomics Study to Reveal the Mechanisms of Bushen Huoxue Formula in Intervertebral Disc Degeneration Treatment
by: Guo J, et al.
Published: (2024)

Exploring the Regulatory Mechanism of Hedysarum Multijugum Maxim.-Chuanxiong Rhizoma Compound on HIF-VEGF Pathway and Cerebral Ischemia-Reperfusion Injury's Biological Network Based on Systematic Pharmacology
by: Kailin Yang, et al.
Published: (2021)

Pharmacological effects and target analysis of Guipi wan in the treatment of cerebral ischemia-reperfusion injury
by: Jianfeng Zhang, et al.
Published: (2024)

Revealing the Underlying Mechanism of Ischemia Reperfusion Injury Using Bioinformatics Approach
by: Bingbing Shen, et al.
Published: (2014)

MAPK Signaling Pathways in Hepatic Ischemia/Reperfusion Injury
by: Yu B, et al.
Published: (2023)

Gene Network Mechanism of Zhilong Huoxue Tongyu Capsule in Treating Cerebral Ischemia-Reperfusion
by: Na Li, et al.
Published: (2022)

TLR2 and TLR4 in the Brain Injury Caused by Cerebral Ischemia and Reperfusion
by: Ying Wang, et al.
Published: (2013)

Efficacy and safety of naotaifang capsules for hypertensive cerebral small vessel disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled clinical trial
by: Rui Fang, et al.
Published: (2023)

Intermedin Alleviates Renal Ischemia-Reperfusion Injury and Enhances Neovascularization in Wistar Rats
by: Wang Y, et al.
Published: (2020)

Integrating network analysis and experimental validation to reveal the mitophagy-associated mechanism of Yiqi Huoxue (YQHX) prescription in the treatment of myocardial ischemia/reperfusion injury
by: Mingtai Chen, et al.
Published: (2023)

Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart
by: Kristína Ferenczyová, et al.
Published: (2021)

P01.04. Attenuation of neurological dysfunction and brain infarction with a chinese herbal formula in ischemia-reperfusion induced brain injury of mice
by: Cheng F, et al.
Published: (2012)

Network Pharmacology and Machine Learning Reveal Salidroside’s Mechanisms in Idiopathic Pulmonary Fibrosis Treatment
by: Ding C, et al.
Published: (2024)

Tongguan capsule for treating myocardial ischemia-reperfusion injury: integrating network pharmacology and mechanism study
by: Jiantao Liu, et al.
Published: (2023)

Investigation of the Mechanisms and Experimental Verification of Yulin Formula in the Treatment of Diminished Ovarian Reserve via Network Pharmacology
by: Wang R, et al.
Published: (2023)

Experimental Study on the Role of Apelin-13 in Alleviating Spinal Cord Ischemia Reperfusion Injury Through Suppressing Autophagy
by: Xu Z, et al.
Published: (2020)

LncRNA SNHG4 Attenuates Inflammatory Responses by Sponging miR-449c-5p and Up-Regulating STAT6 in Microglial During Cerebral Ischemia-Reperfusion Injury
by: Zhang S, et al.
Published: (2020)

Physcion Protects Rats Against Cerebral Ischemia-Reperfusion Injury via Inhibition of TLR4/NF-kB Signaling Pathway
by: Dong X, et al.
Published: (2021)

Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity
by: Xu J, et al.
Published: (2021)

Network Pharmacology and Molecular Docking Reveal the Mechanism of Isodon ternifolius (D. Don) Kudo Against Liver Fibrosis
by: Deng J, et al.
Published: (2023)

Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation
by: Difei Zhang, et al.
Published: (2021)

Effects and Potential Mechanism of Zhuyu Pill Against Atherosclerosis: Network Pharmacology and Experimental Validation
by: Pan Y, et al.
Published: (2023)

Protective Effects of Remimazolam on Cerebral Ischemia/Reperfusion Injury in Rats by Inhibiting of NLRP3 Inflammasome-Dependent Pyroptosis
by: Shi M, et al.
Published: (2022)

Exploring Cuproptosis-Related Genes and Diagnostic Models in Renal Ischemia-Reperfusion Injury Using Bioinformatics, Machine Learning, and Experimental Validation
by: Xu C, et al.
Published: (2024)

The Alterations in Mitochondrial Dynamics Following Cerebral Ischemia/Reperfusion Injury
by: Jirapong Vongsfak, et al.
Published: (2021)

Metabolomics profiling to characterize cerebral ischemia-reperfusion injury in mice
by: Qiong Chen, et al.
Published: (2023)

Sodium danshensu attenuates cerebral ischemia-reperfusion injury by targeting AKT1
by: Qing Gao, et al.
Published: (2022)

DNase I and Sivelestat Ameliorate Experimental Hindlimb Ischemia-Reperfusion Injury by Eliminating Neutrophil Extracellular Traps
by: Wang CL, et al.
Published: (2023)

Protective potential of hydroxysafflor yellow A in cerebral ischemia and reperfusion injury: An overview of evidence from experimental studies
by: Lu Yu, et al.
Published: (2022)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
by: Meng Li, et al.
Published: (2022)

Anti-Myocardial Ischemia Reperfusion Injury Mechanism of Dried Ginger-Aconite Decoction Based on Network Pharmacology
by: Feng Xie, et al.
Published: (2021)

Exploring the Mechanism of Salvianolic Acid B against Myocardial Ischemia-Reperfusion Injury Based on Network Pharmacology
by: Qianping Mao, et al.
Published: (2024)

Deciphering the Mechanism of Xijiao Dihuang Decoction in Treating Psoriasis by Network Pharmacology and Experimental Validation
by: Guo Y, et al.
Published: (2023)